Cormorant Asset Management LP 13D and 13G filings for Immuneering Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 3:03 pm Sale | 2024-09-30 | 13G | Immuneering Corporation IMRX | Cormorant Asset Management LP | 0 0.000% | -1,700,000 (Position Closed) | Filing |
| 2024-04-15 6:10 pm Sale | 2024-04-03 | 13G | Immuneering Corporation IMRX | Cormorant Asset Management LP | 1,700,000 5.810% | -2,504,364 (-59.57%) | Filing |
| 2023-04-24 5:26 pm Purchase | 2023-04-20 | 13G | Immuneering Corporation IMRX | Cormorant Asset Management LP | 4,204,364 14.420% | 1,918,183 (+83.90%) | Filing |
| 2023-02-14 3:13 pm Purchase | 2022-12-31 | 13G | Immuneering Corporation IMRX | Cormorant Asset Management LP | 2,286,181 8.660% | 33,553 (+1.49%) | Filing |
| 2021-08-13 4:01 pm Purchase | 2021-08-03 | 13G | Immuneering Corporation IMRX | Cormorant Asset Management LP | 2,252,628 8.830% | 2,252,628 (New Position) | Filing |